Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1986 | 06-1985 | 03-1985 | 06-1984 | 03-1984 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,422 | 1,929 | 1,929 | 158 | 158 |
| Receivables | 5 | 0 | 0 | 0 | 0 |
| Inventories | 22 | 0 | 0 | 0 | 0 |
| Other current assets | 302 | 42 | 42 | 0 | 0 |
| TOTAL | $2,750 | $1,971 | $1,971 | $158 | $158 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 26 | 24 | 24 | 27 | 27 |
| TOTAL | $26 | $24 | $24 | $27 | $27 |
| Total Assets | $3,210 | $2,331 | $2,331 | $185 | $185 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 134 | 229 | 229 | 0 | 0 |
| Accrued Expenses | 459 | 358 | 358 | 30 | 30 |
| Other current liabilities | 0 | 0 | 0 | 6 | 6 |
| TOTAL | $593 | $587 | $587 | $36 | $36 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $593 | $587 | $587 | $36 | $36 |
| Shareholders' Equity | |||||
| Common Shares | 3 | 3 | 3 | 2 | 2 |
| Retained earnings | -2,898 | -1,174 | -1,174 | -119 | -119 |
| Other shareholders' equity | 5,120 | 2,654 | 2,654 | 240 | 240 |
| TOTAL | $2,617 | $1,744 | $1,744 | $149 | $149 |
| Total Liabilities And Equity | $3,210 | $2,331 | $2,331 | $185 | $185 |